The Patent Finder
US

Purification of Proteins With Cationic Surfactant

US 9,534,013 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Horizon Pharma Rheumatology LLC, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Sep 10, 2027 · High confidence

Filed Aug 14, 2009 as application 11/918,292 · Granted Jan 3, 2017
Base term plus 516 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2006 2027
Clock starts
Apr 12, 2006
Term ends
Sep 10, 2027
Granted
Jan 3, 2017
base term patent term adjustment fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
516
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 516 days past its 20-year base term on prosecution delay. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 12, 2006, when application PCT/US2006/013751, the earliest non-provisional in its chain, was filed (this one was filed Aug 14, 2009)Apr 12, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+516 days, USPTO patent term adjustment recordSep 10, 2027High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 10, 2027High confidence

This family

US 9,534,013this patent
Sep 2027
Sep 2027
Application 15/356,046Abandoned
not computed
not computed
Application 16/455,073Abandoned
not computed
not computed
Application 17/325,555Abandoned
not computed
not computed
Application 18/376,684Abandoned
not computed
not computed
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 18, 2008
Reel 20383, frame 946
Fischer, Meir; Harosh, EliyahuSavient Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jun 12, 2012
Reel 28363, frame 40
Savient Pharmaceuticals, Inc.Morgan Stanley Senior Funding Inc.Security Agreement
Jul 23, 2013
Reel 30936, frame 72
Savient Pharmaceuticals, Inc.U.S. National Bank Association, as Collateral AgentCorrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement.
Feb 21, 2014
Reel 32319, frame 77
Crealta Pharmaceuticals LLCJefferies Finance LLC, as Collateral AgentSecurity Agreement
Mar 4, 2014
Reel 32384, frame 285
Crealta Pharmaceuticals LLCFifth Street Finance Corp., as Collateral AgentSecurity Agreement
Apr 15, 2014
Reel 32675, frame 936
Savient Pharmaceuticals, Inc.; Savient Pharma Holdings, LLCCrealta Pharmaceuticals LLCAssignment of Assignor's Interest
Jan 13, 2016
Reel 37483, frame 49
Fifth Street Finance Corp., as Collateral AgentCrealta Pharmaceuticals LLCRelease of Security Interest
Jan 13, 2016
Reel 37483, frame 148
Jefferies Finance LLC, as Collateral AgentCrealta Pharmaceuticals LLCRelease of Security Interest
Sep 16, 2016
Reel 40059, frame 7
Horizon Pharma Rheumatology LLC (Formerly Known as Crealta Pharmaceuticals LLC)Citibank, N.A., as Collateral AgentPatent Security Agreement
Nov 18, 2016
Reel 40648, frame 361
Crealta Pharmaceuticals LLCHorizon Pharma USA Rheumatology LLCChange of Name
Nov 18, 2016
Reel 40648, frame 367
Horizon Pharma USA Rheumatology LLCHorizon Pharma Rheumatology LLCChange of Name
Oct 31, 2022
Reel 61805, frame 76
Horizon Pharma Rheumatology LLCHorizon Therapeutics USA, Inc.Assignment of Assignor's Interest
Dec 1, 2022
Reel 62073, frame 930
Horizon Pharma Rheumatology LLCHorizon Therapeutics USA, Inc.Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 061805 Frame 0076. Assignor(S) Hereby Confirms the Assignment.
Jun 16, 2023
Reel 64009, frame 261
Savient Pharmaceuticals, Inc.; Savient Pharma Holdings, Inc.Crealta Pharmaceuticals LLCCorrective Assignment to Correct the Seller's Name and Execution Date Previously Recorded on Reel 032675 Frame 0936. Assignor(S) Hereby Confirms the Seller's Name Should Read Savient Pharma Holdings, Inc. and the Execution Date for Both Parties Should Read 01/09/2014.
Oct 6, 2023
Reel 65178, frame 965
Citibank, N.a.Horizon Therapeutics USA, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited